ReviewExpert review of anticancer therapy2022

Tebentafusp for the treatment of HLA-A*02:01-positive adult patients with unresectable or metastatic uveal melanoma.

Lanyi Nora Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.